BioDuro, LLC – FDA 483, Sep 6, 2019
Anchen Pharmaceuticals, Inc. in Irvine, CA, was cited for significant deficiencies in its manufacturing operations, particularly concerning laboratory controls and quality unit procedures. The inspection revealed issues with inadequate testing procedures for incoming materials and water hold times, as well as incomplete laboratory records for calculations. Furthermore, the firm failed to submit a required NDA Field Alert Report for a distributed product complaint and had an overdue investigation into foreign particles found during production.
ID · d422b794-23ae-4ee2-a7e2-14e1d74823ad
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.